These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19167496)

  • 1. 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer.
    Jansson A
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):64-7. PubMed ID: 19167496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
    Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer.
    Oduwole OO; Li Y; Isomaa VV; Mäntyniemi A; Pulkka AE; Soini Y; Vihko PT
    Cancer Res; 2004 Oct; 64(20):7604-9. PubMed ID: 15492288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.
    Jansson A; Delander L; Gunnarsson C; Fornander T; Skoog L; Nordenskjöld B; Stål O
    Clin Cancer Res; 2009 May; 15(10):3610-6. PubMed ID: 19401349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of COX-2 and steroid converting enzymes in breast cancer.
    Gunnarsson C; Jansson A; Holmlund B; Ferraud L; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
    Oncol Rep; 2006 Aug; 16(2):219-24. PubMed ID: 16820896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymes as modulators in malignant transformation.
    Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
    Jansson A; Gunnarsson C; Stål O
    Endocr Relat Cancer; 2006 Sep; 13(3):875-84. PubMed ID: 16954436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of 17beta-hydroxysteroid dehydrogenase type 1 and type 2.
    Vihko P; Isomaa V; Ghosh D
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):71-6. PubMed ID: 11165013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.
    Gunnarsson C; Hellqvist E; Stål O
    Br J Cancer; 2005 Feb; 92(3):547-52. PubMed ID: 15685233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.
    Miki Y; Suzuki T; Sasano H
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):68-71. PubMed ID: 19444935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptors and estrogen-metabolizing enzymes in human ovaries during fetal development.
    Vaskivuo TE; Mäentausta M; Törn S; Oduwole O; Lönnberg A; Herva R; Isomaa V; Tapanainen JS
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3752-6. PubMed ID: 15784714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
    Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
    Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen metabolism as a regulator of estrogen action in the mammary gland.
    Miettinen M; Isomaa V; Peltoketo H; Ghosh D; Vihko P
    J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):259-70. PubMed ID: 14973388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.